Statins and pancreatic cancer.

Gong, Jun; Sachdev, Esha; Robbins, Lori A; Lin, Emily; Hendifar, Andrew E; Mita, Monica M

Gong, Jun; Sachdev, Esha; Robbins, Lori A; Lin, Emily; Hendifar, Andrew E; Mita, Monica M.

Afiliación

Gong J; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.
Sachdev E; Department of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Robbins LA; Department of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Lin E; Department of Internal Medicine, Harbor-UCLA Medical Center, Torrance, CA 90509, USA.
Hendifar AE; Department of Internal Medicine, Division of Medical Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Mita MM; Experimental Therapeutics Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Oncol Lett ; 13(3): 1035-1040, 2017 Mar.

Article en En | MEDLINE | ID: mdl-28454210

Palabras clave

chemoprevention; metabolic syndrome; obesity; pancreatic cancer; statins

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google